CDDD11-8
CDDD11-8 is a potent, orally bioavailable small molecule inhibitor targeting CDK9 and FLT3-ITD with high selectivity (Ki = 8 nM and 13 nM, respectively) . It demonstrates strong anti-proliferative effects in vitro against FLT3-ITD-positive leukemia cell lines and has shown efficacy in relevant in vivo models, supporting its use in oncology research for acute myeloid leukemia.
Product Specifications
CAS Number
2241659-94-7
Field of Research
Cardiovascular Research, Cell Biology, Signal Transduction
Smiles
CC=1C (C=2N3C (=NC2) C=CC (=C3) C4=CC=CC=C4) =NC (N[C@@H]5CC[C@@H] (N) CC5) =NC1
Molecular Formula
C24H26N6
Molecular Weight
398.50
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1208770 Inquire
Recombinant Rabbit C-X-C chemokine receptor type 2 (CXCR2)
Sign In for Pricing
View Details 
AAP39424-100UG 100 µg
ZNF286 Peptide - C-terminal region (AAP39424)
Sign In for Pricing
View Details